Human FOSL1/FRA/fra-1 ORF/cDNA clone-Adenovirus plasmid (NM_005438.5)
Cat. No.: pGMAD001391
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human FOSL1/FRA/fra-1 adenoviral expression plasmid for FOSL1 adenovirus packaging, FOSL1 adenovirus.
Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.
Go to
FOSL1/FRA products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
Catalog ID | pGMAD001391 |
Gene Name | FOSL1 |
Accession Number | NM_005438.5 |
Gene ID | 8061 |
Species | Human |
Product Type | Adenovirus plasmid (overexpression) |
Insert Length | 816 bp |
Gene Alias | FRA,fra-1,FRA1 |
Fluorescent Reporter | EGFP |
Mammalian Cell Selection | Null |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | EF1 |
Resistance | Kanamycin |
ORF Nucleotide Sequence | ATGTTCCGAGACTTCGGGGAACCCGGCCCGAGCTCCGGGAACGGCGGCGGGTACGGCGGCCCCGCGCAGCCCCCGGCCGCAGCGCAGGCAGCCCAGCAGAAGTTCCACCTGGTGCCAAGCATCAACACCATGAGTGGCAGTCAGGAGCTGCAGTGGATGGTACAGCCTCATTTCCTGGGGCCCAGCAGTTACCCCAGGCCTCTGACCTACCCTCAGTACAGCCCCCCACAACCCCGGCCAGGAGTCATCCGGGCCCTGGGGCCGCCTCCAGGGGTACGTCGAAGGCCTTGTGAACAGATCAGCCCGGAGGAAGAGGAGCGCCGCCGAGTAAGGCGCGAGCGGAACAAGCTGGCTGCGGCCAAGTGCAGGAACCGGAGGAAGGAACTGACCGACTTCCTGCAGGCGGAGACTGACAAACTGGAAGATGAGAAATCTGGGCTGCAGCGAGAGATTGAGGAGCTGCAGAAGCAGAAGGAGCGCCTAGAGCTGGTGCTGGAAGCCCACCGACCCATCTGCAAAATCCCGGAAGGAGCCAAGGAGGGGGACACAGGCAGTACCAGTGGCACCAGCAGCCCACCAGCCCCCTGCCGCCCTGTACCTTGTATCTCCCTTTCCCCAGGGCCTGTGCTTGAACCTGAGGCACTGCACACCCCCACACTCATGACCACACCCTCCCTAACTCCTTTCACCCCCAGCCTGGTCTTCACCTACCCCAGCACTCCTGAGCCTTGTGCCTCAGCTCATCGCAAGAGTAGCAGCAGCAGCGGAGACCCATCCTCTGACCCCCTTGGCTCTCCAACCCTCCTCGCTTTGTGA |
ORF Protein Sequence | MFRDFGEPGPSSGNGGGYGGPAQPPAAAQAAQQKFHLVPSINTMSGSQELQWMVQPHFLGPSSYPRPLTYPQYSPPQPRPGVIRALGPPPGVRRRPCEQISPEEEERRRVRRERNKLAAAKCRNRRKELTDFLQAETDKLEDEKSGLQREIEELQKQKERLELVLEAHRPICKIPEGAKEGDTGSTSGTSSPPAPCRPVPCISLSPGPVLEPEALHTPTLMTTPSLTPFTPSLVFTYPSTPEPCASAHRKSSSSSGDPSSDPLGSPTLLAL |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-T89299-Ab | Anti-FOSL1 monoclonal antibody |
Target Antigen | GM-Tg-g-T89299-Ag | FOSL1 protein |
ORF Viral Vector | pGMLP002676 | Human FOSL1 Lentivirus plasmid |
ORF Viral Vector | pGMLV001888 | Human FOSL1 Lentivirus plasmid |
ORF Viral Vector | pGMLV002226 | Human FOSL1 Lentivirus plasmid |
ORF Viral Vector | pGMAD001391 | Human FOSL1 Adenovirus plasmid |
ORF Viral Vector | vGMLP002676 | Human FOSL1 Lentivirus particle |
ORF Viral Vector | vGMLV001888 | Human FOSL1 Lentivirus particle |
ORF Viral Vector | vGMLV002226 | Human FOSL1 Lentivirus particle |
ORF Viral Vector | vGMAD001391 | Human FOSL1 Adenovirus particle |
Target information
Target ID | GM-T89299 |
Target Name | FOSL1 |
Gene Group Identifier (Target Gene ID in Homo species) |
8061 |
Gene ID |
100051930 (Equus caballus), 101101337 (Felis catus), 106993191 (Macaca mulatta), 14283 (Mus musculus) 25445 (Rattus norvegicus), 483724 (Canis lupus familiaris), 531389 (Bos taurus), 8061 (Homo sapiens) |
Gene Symbols & Synonyms | FOSL1,Fosl1,Fra1,fra-1,Fra-1,FRA,FRA1 |
Target Alternative Names | FOSL1,Fos-related antigen 1,FRA-1,FRA,FRA1,fra-1 |
Uniprot Accession |
P10158,P15407,P48755
Additional SwissProt Accessions: P48755,P10158,P15407 |
Uniprot Entry Name | |
Protein Sub-location | Introcelluar Protein |
Category | Therapeutics Target |
Disease | cancer |
Disease from KEGG | Wnt signaling pathway, Osteoclast differentiation, IL-17 signaling pathway, Human T-cell leukemia virus 1 infection |
Gene Ensembl | ENSECAG00000023092, ENSMMUG00000008653, ENSMUSG00000024912, ENSCAFG00845017398, ENSBTAG00000006194, ENSG00000175592 |
Target Classification | Tumor-associated antigen (TAA) |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.